|
Epitope |
Antibody |
Protocols from
previous
runs |
|
A
B
C
D
E
F
G
H
M
K
P
S
T
V |
|
ASMA |
mAb 1A4 |
Malmö, SE
(Run 10)
■
Sønderborg, DK
(Run 10)
■
Täby, SE
(Run 10) |
|
Bcl-2 |
mAb 124 |
Aalborg,
DK
(Run 3) ■
Tampere,
FI
(Run 3) |
|
bcl-6 |
mAb PG-B6p |
Aalborg,
DK (Run 4) |
|
Calretinin
(CR) |
mAb 5A5 |
Hillerød, DK
(Run 17)
■
Hillerød, DK (Run 19)
■
Ålesund,
N (Run 6) |
|
mAb DAK-Calret 1 |
Molde, NO (Run 19)
■
Næstved, DK
(Run 17)
■
Saskatoon, CA
(Run 17)
■
Skive,
DK (Run 6) |
|
pAb 18-0211 |
Trondheim, NO
(Run 17)
■
Wien, AT (Run 19) |
|
pAb 7699/4 |
Odense, DK (Run 19) |
|
CD3 |
mAb F7.2.38 |
Skien, NO
(Run 14) |
|
mAb PS1 |
Castelfranco
Veneto, IT
(Run 14)
■
Guangzhou, CHN
(Run 14)
■
Rad.hosp.
Oslo, NO (Run 5) |
|
mAb SP7 |
Ålesund, NO
(Run 14) |
|
pAb A0452 |
Holbæk/Slagelse, DK (Run 14)
■
Lindköping, SE (Run 5) |
|
pAb RB-360-A |
Rovaniemi, FI
(Run 14) |
|
CD5 |
mAb 4C7 |
Aalborg,DK (Run
3)
■
Glostrup, DK (Run
8)
■
Oslo, NO (Run
3)
■
Skien, NO (Run 8) |
|
mAb
CD5/54/F6 |
Hjørring/Brønderslev, DK
(Run 8) |
|
CD10 |
mAb 56C6 |
Hillerød, DK (Run
6)
■
Karlstad, SE (Run
6) |
|
CD15 |
mAb C3D-1 |
Glostrup, DK
(Run 10)
■
Oslo, NO (Run
3)
■
Örebro, SE
(Run 14) |
|
mAb MMA |
Aalborg, DK
(Run 3)
■ Karlstad, SE (Run
10)
■
Tampere, FI
(Run 14)
■
Treviglio, IT
(Run 14) |
|
mAb Tu9 |
Anonymous
(Run 10) |
|
CD20 |
mAb L26 |
Helsingborg, SE (Run
6)
■
Skive, DK
(Run 6) |
|
CD23 |
mAb 1B12 |
Esbjerg, DK (Run
9)
■
Odense, DK (Run
9) ■
Skien, NO (Run 9) |
|
mAb MHM6 |
Stavanger, NO (Run
9) |
|
CD34 |
mAb QBEnd 10 |
Aalborg, DK
(Run 1) |
|
CD79a |
mAb JCB117 |
Carolinska Sgh, Stockholm, SE (Run
6)
■
Vejle, DK (Run
6) |
|
CD117 |
pAb A4502 |
Aalborg, DK
(Run 4)
■
Bergen, NO
(Run 14) ■
Lindköping, SE
(Run 7)
■
Trondheim, NO
(Run 4)
■
Trondheim, NO (Run 7)
■
Vejle, DK (Run
7)
■
Vestfold, NO (Run 7)
■
Århus, DK
(Run 14) |
|
Chromogranin |
mAb LK2H10 |
Aalborg, DK
(Run 13)
■
Firenze, IT
(Run 18)
■
Lund, SE (Run
2)
■
Uppsala, SE (Run
9)
■
Uppsala, SE
(Run 18) |
|
mAb LK2H10+PHE5 |
Jyväskylä, FI
(Run 9)
■
Jyväskylä, FI
(Run 13)
■
Jyväskylä, FI
(Run 18)
|
|
pAb A0430 |
Danderyd Stockholm;
SE (Run 13)
■
Helsingborg,
SE
(Run 18)
■
Helsingki, FI (Run
9)
■
Reykjavik,
IS
(Run 18)
■
RH. København, DK
(Run 2)
■
Vejle, DK (Run
9) |
|
Cyclin D1 |
mAb P2D11F11 |
Næstved, DK (Run
9)
■
Seinäjoki, FI (Run
9)
■
Uppsala, SE (Run
9) |
|
mAb SP4 |
Drammen, NO
(Run 17)
■
Trollhättan, SE (Run 17)
■
Ålesund, NO (Run
9) |
|
pAb CP236 |
Skive, DK
(Run 17) |
|
Cytokeratin,
low molecular weight |
mAb 5D3 |
Jönköping, SE
(Run 9) |
|
mAb C-51 |
Aalborg, DK (Run 2)
■
Tampere, FI (Run
9)
■
Tampere, FI
(Run 16) |
|
mAb CAM 5.2 |
Lindköping, SE
(Run 9)
■
Oslo, NO (Run 2) |
|
mAb DC10 |
Eindhoven,
NL (Run 16)
■
Esbjerg, DK
(Run 16)
■ Roskilde, DK
(Run 9) |
|
Cytokeratin, pan- |
mAb
AE1/AE3 |
Helsingborg,
SE (Run 15)
■
Odense, DK (Run 8) |
|
mAb
AE1/AE3+5D3 |
RH. København, DK (Run
8)
■
RH,
København, DK (Run 15) |
|
mAb Ab-2 |
Rovaniemi,
FI (Run 15) |
|
mAb KL1 |
Esbjerg, DK
(Run 15)
■
Skive, DK (Run 8) |
|
mAb MNF116 |
Bergen, NO
(Run 15) |
|
Desmin |
mAb D33 |
Lund, SE (Run 5) |
|
mAb DE-R-11 |
Odense, DK (Run 5) |
|
Epithelial antigen (Ep-CAM) |
mAb Ber-EP4 |
Bispebjerg Hosp.,
Kbh., DK (Run 6)
■
Bodø, NO
(Run 17)
■
Lund, SE
(Run 17)
■
RH, Kbh., DK (Run
6) |
|
mAb MOC-31 |
Odense,
DK (Run 17) |
|
Estrogen receptor |
mAb 1D5 |
Bispebjerg Hosp.,
Kbh., DK (Run 13) ■
Esbjerg, DK
(Run 10)
■
Halmstad, SE
(Run B1)
■
Halmstad, SE
(Run B3)
■
Hjørring/Brønderslev,
DK (Run 8) ■
Trondheim, NO (Run
8) |
|
mAb1D5 and ER-2-123 |
Anonymous
(Run B1) |
|
mAb 6F11 |
Gävle, SE (Run
10)
■
Helsinki, FI
(Run B1) ■
Irvine, USA
(Run B1) ■
Jönköping, SE (Run 8)
■
Karlstad, SE (Run 8)
■
Odense, DK (Run
10)
■
Roskilde, DK
(Run B3)
■
Stavanger, NO
(Run 13) |
|
rmAb SP1 |
Aalborg, DK (Run
10)
■
Kalmar, SE
(Run B1)
■
Karolinska
Stockholm, SE (Run 13)
■
Roermond, NL
(Run B3)
■
Skien, NO
(Run B3) |
|
Glial fibrillary acidic protein |
mAb 6F2 |
Karlstad,
SE (Run 4) |
|
pAb Z0334 |
Aalborg,
DK (Run 4) |
|
HER-2 |
mAb 4B5 |
Treviglio,
IT
(Run B2) |
|
mAb CB11 |
Turku, FI (pilot run) |
|
rmAb SP3 |
Drammen,
NO
(Run B2)
■
Tilburg,
NL
(Run B4) |
|
pAb A0485 |
Dresden,
DE
(Run B4)
■
Guangzhou,
CHN
(Run B2)
■
Luleå, SE
(Run B3)
■
Stockholm, SE (pilot run) |
|
pAb 28-0004 |
Helsingborg, SE (pilot run) |
|
HercepTest |
Hjørring, DK (pilot run)
■
Vejle, DK
(Run B2) |
|
Pathway |
Frederiksstad, NO (pilot run) |
|
IgK |
pAb A0191 |
Odense, DK
(Run 18)
■
Stavanger, NO
(Run 15)
■
Seinäjoki, FI
(Run 15)
■
Seinäjoki,
FI
(Run 18) |
|
IgM |
pAb A0425 |
Hvidovre, DK
(Run 18)
■
Skövde, SE
(Run 18) |
|
Ki67 |
mAb MIB-1 |
Herlev, DK
(Run 5)
■
Trondheim, NO (Run 5) |
|
MLA |
mAb A103 |
Jönköping, SE
(Run 16)
■
Karlstad, SE (Run
7)
■
Norbyhagen, NO (Run
7)
■
Stavanger, NO
(Run 16) |
|
mAb
M2-7C10+M2-9E3 |
Jyväskylä, FI
(Run 7) |
|
Mismatch repair proteins
MSH2 |
mAb 25D12 |
Aalborg, DK
(Run 13) |
|
mAb 27 |
Odense, DK
(Run 13) |
|
mAb FE11 |
Ålesund, NO
(Run 13) |
|
MSA-HMB45 |
mAb HMB45 |
Jyväskylä, FI
(Run 7)
■
Norbyhagen, NO (Run 7)
■
Sønderborg, DK (Run
7)
■
Västerås, SE (Run 7) |
|
p53 |
mAb DO-7 |
Tampere,
FI
(Run 2) |
|
Progesterone receptor |
mAb 16 |
Karlstad, SE
(Run 10)
■
Næstved, DK
(Run B2) |
|
mAb 1A6 |
Gävle, SE
(Run10) |
|
mAb 1E2 |
Nieuwegein,
NL (Run B2) |
|
mAb PgR 636 |
Danderyd, Stockholm,
SE
■ (Run 10)Skien, NO
(Run B2)
|
|
mAb PgR 1294 |
Aliso Viejo,
USA (Run B2) |
|
mAb PR88 |
Skive, DK
(Run 10) |
|
mAb SP2 |
Kalmar, SE
(Run B2) |
|
S-100 |
pAb Z0311 |
Borås, SE (Run 7)
■
Hjørring/Brønderslev, DK
(Run 7)
■
Odense, DK (Run 7) |
|
SYP |
mAb 27G12 |
Gävle, SE
(Run 18)
■
Trollhättan,
SE
(Run 18) |
|
mAb Snp88 |
Gentofte, DK
(Run 18)
■
Næstved, DK (Run 5)
■
Roskilde, DK
(Run 18) |
|
mAb SP11 |
Eindhoven,
NL
(Run 18) |
|
pAb A0010 |
Herlev, DK (Run
5)
■
Ålesund, NO
(Run 18) |
|
pAb RB-9044 |
Fujian, CHN
(Run 18) |
|
TTF-1 |
mAb 8G7G3/1 |
Herlev, DK (Run
9)
■
Jyväskylä, FI
(Run 9) |
|
mAb SPT24 |
Dramme, NO (Run 19)
■
Hjørring, DK (Run
9)
■
Linköping, SE (Run 19)
■
Luleå, SE (Run
9)
■
Roskilde, DK (Run 19)
■
Sarajevo, BA (Run 19)
■
Ålesund, NO
(Run 19) |
|
